Adenovirus type 4 a

Ended Awarded

Contract number
SPE2DP21F3212
Awardee
Awarding agency
Obligated
$282,354

Award facts

Contract value 100% obligated
$282,353.76 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Parsippany, NJ 07054, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc. on April 6, 2021. The contract is for the delivery of Adenovirus Type 4 vaccine, with a potential value of $282,353.76 and a completion date of April 27, 2021. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that has provided various drug products, including vaccines and respiratory treatments, to federal customers such as the Department of Defense and Department of Veterans Affairs through delivery orders and indefinite delivery contracts. This contract does not have a set-aside designation.

Quick answers

Who was awarded contract SPE2DP21F3212?

SPE2DP21F3212 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on April 6, 2021.

How much is contract SPE2DP21F3212 worth?

The government has obligated $282,354 on SPE2DP21F3212.

Is contract SPE2DP21F3212 an order under another contract?

Yes. SPE2DP21F3212 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.

Was contract SPE2DP21F3212 competed?

The extent of competition for SPE2DP21F3212 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login